Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal

France Nouvelles Nouvelles

Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
France Dernières Nouvelles,France Actualités
  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech after clinching a pact with Japan’s Daiichi Sankyo Co., dealing a fresh blow to companies in China seeking to prove their chop in developing innovative cancer therapies.

Switzerland Right-Wing Party Set for Best Result Ever, NZZ SaysRoche Taps AI to Find Lung Cancer Patients After Trial SuccessJapan Begins Probe Into Google for Alleged Antitrust ViolationsUK Pushing Pensions Into Private Equity Draws Industry BacklashEuropean Banks’ Bumper Profits Overshadowed by Global TensionsChina Lifts Australia Wine Tariffs as Albanese Sets Visit DatesA Shrinking $1.

29 for Stellantis strike deadline as talks set to beginChampagne says he wishes grocers were more 'forthcoming' on plans to stabilize pricesSwitzerland Right-Wing Party Set for Best Result Ever, NZZ SaysAsia Stocks Set For Losses as US Volatility Rises: Markets WrapChina Lifts Australia Wine Tariffs as Albanese Sets Visit DatesArgentina Markets Brace for Selloff After Massa Forces RunoffPhilippines Says China Provocation at Sea Won’t Deter OperationsChina Rattles Foreign Firms Again...

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

BNNBloomberg /  🏆 83. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Merck, Seagen Drug Cocktail Seen as New Bladder Cancer StandardMerck, Seagen Drug Cocktail Seen as New Bladder Cancer StandardMerck & Co. and Seagen Inc.’s drug cocktail is set to replace chemotherapy as a first choice for bladder cancer patients, doctors said, the first alternative to the toxic treatment in 30 years.
Lire la suite »

Merck, Seagen Drug Cocktail Seen as New Bladder Cancer StandardMerck, Seagen Drug Cocktail Seen as New Bladder Cancer StandardMerck & Co. and Seagen Inc.’s drug cocktail is set to replace chemotherapy as a first choice for bladder cancer patients, doctors said, the first alternative to the toxic treatment in 30 years.
Lire la suite »

British Rice Industry Fears India Pact Will Kill Off Local MillsBritish Rice Industry Fears India Pact Will Kill Off Local MillsIndustry warns cutting tariffs in free trade deal would decimate jobs and investment.
Lire la suite »

Top Republicans Emmer, Johnson Join Wide-Open Speakership RaceTop Republicans Emmer, Johnson Join Wide-Open Speakership RaceRepresentatives Tom Emmer and Mike Johnson entered the race for US House speaker, throwing two high-ranking Republicans into the mix of a crowded pool of candidates.
Lire la suite »

Republicans Unveil Nine Candidates to End House Speaker DeadlockRepublicans Unveil Nine Candidates to End House Speaker DeadlockHouse Republicans set up a nine-man contest for the speaker’s post on Sunday, signaling what may be a drawn-out vote to fill the vacancy this week.
Lire la suite »



Render Time: 2025-03-04 10:09:50